Immuron Ltd. (IMRN) intrinsic value & 10-year financials

Immuron Ltd. (IMRN) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 24.7% a year to AUD 7.3M, with an average return on invested capital of -57.7%.

Graham intrinsic value
—
Revenue (FY2025)
AUD 7.3M
Revenue growth (10-yr CAGR)
24.7%
ROIC (10-yr avg)
-57.7%
Free cash flow (FY2025)
—

IMRN 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 AUD 7.3M -AUD 5.2M -AUD 2.26 — -73.3% -50.2%
FY2024 AUD 4.9M -AUD 6.9M -AUD 3.04 -AUD 5.9M -118.3% -42.9%
FY2023 AUD 1.8M -AUD 3.8M -AUD 1.66 -AUD 2.6M -197.8% -13.3%
FY2022 AUD 765.2K -AUD 2.9M -AUD 1.25 -AUD 3.2M -375.0% -9.4%
FY2021 AUD 145.8K -AUD 8.4M -AUD 3.79 -AUD 4.1M -5748.5% -42.2%
FY2020 AUD 1.9M -AUD 2.9M — -AUD 3.1M -153.0% -35.1%
FY2019 AUD 2.4M -AUD 4.6M — -AUD 1.8M -194.0% -46.0%
FY2018 AUD 1.8M -AUD 3.0M — -AUD 3.5M -162.1% -86.2%
FY2017 AUD 1.4M -AUD 6.8M — -AUD 7.0M -481.5% -193.9%
FY2016 AUD 1.0M -AUD 7.1M — -AUD 5.2M — —

Source: annual 10-K filings on SEC EDGAR. Figures in AUD.

Executive summary

Immuron Ltd is a consistent compounder, expanding top-line revenue at 24.7% annually over the past decade.

Immuron Ltd has historically struggled to out-earn its cost of capital, averaging just -44.1% ROIC.

Immuron Ltd has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Immuron Ltd is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-75.07 per share.

IMRN stock: frequently asked questions

What is the intrinsic value of Immuron Ltd. (IMRN) stock?

Graham's formula only works with positive earnings. Immuron Ltd. reported diluted EPS of -AUD 2.26 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

How fast has Immuron Ltd. grown?

Revenue went from AUD 1.0M in fiscal 2016 to AUD 7.3M in fiscal 2025, a compound annual growth rate of 24.7%. Net income was -AUD 5.2M in fiscal 2025.

What is IMRN's return on invested capital?

Average ROIC over the last 10 fiscal years was -57.7%, and average return on equity was -47.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this IMRN data come from?

From Immuron Ltd.'s annual 10-K filings on SEC EDGAR, most recently filed Sep 25, 2025. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks